Octane and Currus automate CAR T manufacturing on Cocoon
Automation to support phase 1 solid tumour trial
Read More
Author: John Pinching
Regulatory filings for lung cancer therapy advance
Progress builds momentum for targeted Hutchmed and AstraZeneca treatment
Read More
Hansa reports positive PAES results for Idefirix at ASN Kidney Week
One‑year graft failure‑free survival reaches 90% in crossmatch‑positive transplants
Read More
Hutchmed reports phase 3 SANOVO data for first‑line lung cancer
Combination shows strong PFS and OS gains in MET‑overexpressing EGFRm disease
Read More
Radiotherapy boosts progression‑free survival in advanced lung cancer
SARON trial shows 56% improvement over standard treatment
Read More
